Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.
Ruggeri RM, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, Brizzi MP, Zumstein L, Pia A, Lania A, Lavezzi E, Nappo G, Laffi A, Albertelli M, Boschetti M, Hasballa I, Veresani A, Prinzi N, Pusceddu S, Oldani S, Nichetti F, Modica R, Minotta R, Liccardi A, Cannavale G, Grossrubatscher EM, Tarsitano MG, Zamponi V, Zatelli MC, Zanata I, Mazzilli R, Appetecchia M, Davì MV, Guarnotta V, Giannetta E, La Salvia A, Fanciulli G, Malandrino P, Isidori AM, Colao A, Faggiano A; NIKE Group. Ruggeri RM, et al. Among authors: veresani a. J Endocrinol Invest. 2024 Apr;47(4):959-971. doi: 10.1007/s40618-023-02213-1. Epub 2023 Oct 14. J Endocrinol Invest. 2024. PMID: 37837555 Free PMC article.
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
Fanciulli G, Modica R, La Salvia A, Grossrubatscher EM, Florio T, Ferraù F, Veresani A, Russo F, Colao A, Faggiano A. Fanciulli G, et al. Among authors: veresani a. Front Endocrinol (Lausanne). 2023 Apr 20;14:1145926. doi: 10.3389/fendo.2023.1145926. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152939 Free PMC article. Review.
"Present and future of immunotherapy in Neuroendocrine Tumors".
Albertelli M, Dotto A, Nista F, Veresani A, Patti L, Gay S, Sciallero S, Boschetti M, Ferone D. Albertelli M, et al. Among authors: veresani a. Rev Endocr Metab Disord. 2021 Sep;22(3):615-636. doi: 10.1007/s11154-021-09647-z. Epub 2021 Apr 14. Rev Endocr Metab Disord. 2021. PMID: 33851319 Free PMC article. Review.